Merck KGaA
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 1MRK.MI | 1795.TW | KNSA | ZYDUSLIFE.BO | SFZN.SW | HIK.L | |
|---|---|---|---|---|---|---|
| Market cap | 59.17B | 45.96B | 6.22B | 1.13T | 3.19B | 3.47B |
| P/E (TTM) | 25.0 | 12.1 | 80.5 | 25.3 | 18.6 | 12.8 |
| Forward P/E | — | 7.3 | 49.3 | 23.0 | 15.4 | 9.0 |
| Price/book | 2.0 | 1.9 | 9.5 | 4.2 | 3.2 | 1.9 |
| Dividend yield | 1.53% | 1.46% | — | 0.09% | 0.56% | 3.85% |
| 1-year change | +27.42% | −38.73% | +105.57% | +10.87% | −12.36% | −7.24% |
| Today | +1.42% | −1.99% | −4.17% | +1.58% | +1.75% | +0.30% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 1MRK.MI news ›Merck KGaA to buy Silence Therapeutics in all-cash deal
Merck KGaA to acquire Silence Therapeutics for $1.3B cash, a 130% premium, boosting siRNA pipeline and rare-disease focus. Merck KGaA (MKGAY) (MKGAF) has agreed to acquire Silence Therapeutics (SLN) in an all-cash deal with an enterprise…
Merck KGaA’s $1.1B Silence Therapeutics Buyout Brings RNA Drug for Rare Blood Cancer
The Silence Therapeutics acquisition gives Merck KGaA a drug ready for a pivotal test in the blood disorder polycythemia vera. Silence’s RNA therapy offers a different approach and a potential dosing advantage over a Takeda Pharmaceutical…
Merck KGaA agrees to buy Silence Therapeutics for roughly $1.1 billion
Merck KGaA struck a cash deal to purchase Silence Therapeutics for about $1.1 billion, valuing each American depositary share at $20. That works out to a 130% premium to Silence's prior close, and traders reacted fast: the stock more than…
Merck KGaA, Darmstadt, Germany, Acquires Silence Therapeutics for $1.3 Billion
Merck KGaA, Darmstadt, Germany, agrees to acquire Silence Therapeutics for roughly $1.3 billion, gaining a siRNA asset, divesiran. Merck KGaA, Darmstadt, Germany, has entered a definitive agreement to acquire Silence Therapeutics, a…
Silence Therapeutics: Downgrade To Hold On Merck KGaA Acquisition And PV siRNA
Merck KGaA is to buy Silence Therapeutics plc for $1.3B cash at $20/ADS (130% premium). Click for a look at SLN and see why I am downgrading it. - Silence Therapeutics plc is being acquired by Merck KGaA in an all-cash $1.3B deal, offering…
Merck KGaA agrees to acquire Silence Therapeutics in $1.3B deal
China’s Q3 GDP grew 4.5% on Oct. 19, inside the 4.5%–5% target, as exports led and property investment fell 20.6%. Several investment firms reported new or increased Tesla holdings in the third quarter, while institutional investors…
Merck KGaA : Jefferies reiterates its Neutral rating
Published on 10/19/2026 at 11:18 am EDT Merck: Operational resilience over the years, cannot be overlooked September 04, 2026 at 08:34 am EDT Merck KGaA: From 19th-century cocaine to tomorrow's AI chips Merck CEO on US Business, Life…
Merck KGaA to Spend $1.3bn on Silence Therapeutics
Merck KGaA (-0.83%, at EUR143.10) announced that it has signed a definitive agreement to acquire British biotechnology company Silence Therapeutics, which specializes in developing therapies based on small interfering RNAs (siRNAs). The…
Silence Therapeutics to be Acquired by Merck KGaA for $20 Per ADS
Silence Therapeutics said Monday it has entered into a definitive agreement to be acquired by Merck KGaA in Darmstadt, Germany in an all-cash deal with an enterprise value of $1.1 billion and an... Biotechnology & Medical Research Silence…
NVIDIA, Microsoft, Merck KGaA Collaborate on AI Patient Support Model
Published on 10/21/2026 at 09:37 am EDT Merck: Operational resilience over the years, cannot be overlooked September 04, 2026 at 08:34 am EDT Merck KGaA: From 19th-century cocaine to tomorrow's AI chips Merck CEO on US Business, Life…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com11
-
openpr.com7
-
seekingalpha.com2
-
stocktitan.net2
-
themarketsdaily.com2
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 33 articles, not a forecast.